Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/11/24 16:15 | 7/9/24 | ANRO | Health | Drug | Pharmaceutical Preparations | Savitz Adam | CA | O | CHIEF ME | P.m | 191 | 12.72 | 0 | 15 | 60 | 40 | I | ||||||||||||||
4/1/24 16:15 | 3/28/24 | ANRO | Health | Drug | Pharmaceutical Preparations | Smith Nicholas Conrad | CA | O | CFO | P | 101 | 16.36 | 0 | 6 | 30 | 27 | D | ||||||||||||||
2/8/24 16:32 | 2/6/24 | ANRO | Health | Drug | Pharmaceutical Preparations | Alpha Wave Global, LP | NY | T | P.d | 9,600 | 16.00 | 0 | 600 | 19 | 3,708 | I | |||||||||||||||
2/7/24 16:40 | 2/6/24 | ANRO | Health | Drug | Pharmaceutical Preparations | Smith Nicholas Conrad | CA | O | CFO | P | 25 | 16.00 | 0 | 2 | New | 2 | D | ||||||||||||||
2/7/24 16:38 | 2/6/24 | ANRO | Health | Drug | Pharmaceutical Preparations | Savitz Adam | CA | O | CHIEF ME | P.d | 272 | 16.00 | 0 | 17 | 217 | 25 | I | ||||||||||||||
2/7/24 16:36 | 2/6/24 | ANRO | Health | Drug | Pharmaceutical Preparations | Etkin Amit | CA | DO | P,CEO | P.d | 50 | 16.00 | 0 | 3 | 0 | 1,205 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |